General Information of This Metabolic Reaction (MR) (ID:
MR001630) |
Formula |
|
Reactant |
Mefenamic acid |
Product |
3-hydroxymethyl Mefenamic Acid |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 2C9 (CYP2C9)
|
DME Info
|
Metabolic Type
|
Oxidation
-
Hydroxylation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Produce The Product of This MR
|
|
References |
1 |
Role of cytochrome P450 2C8 in drug metabolism and interactions. Pharmacol Rev. 2016 Jan;68(1):168-241.
|
2 |
Both reactivity and accessibility are important in cytochrome P450 metabolism: a combined DFT and MD study of fenamic acids in BM3 mutants. J Chem Inf Model. 2019 Feb 25;59(2):743-753.
|
3 |
Metabolism of non-steroidal anti-inflammatory drugs (NSAIDs) by Streptomyces griseolus CYP105A1 and its variants Drug Metab Pharmacokinet. 2022 Aug;45:100455. doi: 10.1016/j.dmpk.2022.100455.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.